Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Autor:	Iulian Pruteanu-Malinici, Alina C. Boesteanu, Noelle V. Frey, Felipe Bedoya, Jennifer Brogdon, Don L. Siegel, Changfeng Zhang, F. Brad Johnson, Megan M. Davis, Edward Pequignot, Regina M. Young, Simon F. Lacey, Yan Wang, David L. Porter, Roddy S. O’Connor, Carl H. June, Sadik H. Kassim, Wei-Ting Hwang, David E Ambrose, Lifeng Tian, Joseph A. Fraietta, Corin L. Dorfmeier, Stefan Lundh, Bruce L. Levine, Jun Xu, Hans Bitter, Fang Chen, Irina Kulikovskaya, Nicholas Wilcox, Mercy Gohil, Harit Parakandi, Alexander C. Huang, E. John Wherry, Li Liu, J. Joseph Melenhorst, Elena Orlando, Minnal Gupta
Rok vydání:	2021
Předmět:	biology business.industry Chronic lymphocytic leukemia General Medicine medicine.disease General Biochemistry Genetics and Molecular Biology Chimeric antigen receptor CD19 Text mining Cancer research biology.protein Medicine CAR T-cell therapy business
Zdroj:	Nature Medicine. 27:561-561
ISSN:	1546-170X 1078-8956
DOI:	10.1038/s41591-021-01248-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6fdbbc013a9884b7f454f421a988e602 https://doi.org/10.1038/s41591-021-01248-2 Zobrazit plný text záznamu Full text from SpringerLink